Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs
Public ClinicalTrials.gov record NCT00062816. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purposes of this Phase 1/2 study are to examine the safety, tolerability, and antiviral activity of ISIS 14803, when given in combination with peginterferon alfa and ribavirin, to patients who either failed to have at least a 100-fold HCV reduction at Week 12 of standard therapy or still have detectable HCV at Week 24.
Study identification
- NCT ID
- NCT00062816
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2003 (Type not available)
- Primary completion
- Jan 2004 (Actual)
- Completion
- Jan 2004 (Type not available)
- Last update posted
- Dec 5, 2022
2003 – 2004
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Gastroenterology Associates | Birmingham | Alabama | 35209 | — |
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Community Clinical Trials | Orange | California | 92868 | — |
| The Lynn Institute of the Rockies | Colorado Springs | Colorado | 80909 | — |
| Western States Clinical Research, Inc. | Wheat Ridge | Colorado | 80033 | — |
| University of Florida | Jacksonville | Florida | 32209 | — |
| Miami Research Associates, Inc. | Miami | Florida | 33173 | — |
| Idaho Gastroenterology Assoc. | Boise | Idaho | 83702 | — |
| IMG Healthcare, LLC | New Orleans | Louisiana | 70127 | — |
| Beth Israel Deconess Medical Center | Boston | Massachusetts | 02215 | — |
| FutureCare Studies | Springfield | Massachusetts | 01107 | — |
| William Beaumont Hospital | Royal Oak | Michigan | 48073 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Cornell Medical Center | New York | New York | 10021 | — |
| Rochester Institute for Digestive Diseases and Sciences, Inc. | Rochester | New York | 14607 | — |
| Duke Clinical Research Institute | Durham | North Carolina | 27705 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45219 | — |
| Blair Gastroenterology Associates | Altoona | Pennsylvania | 16602 | — |
| Gastroenterology Center of the MidSouth, P.C. | Germantown | Tennessee | 38138 | — |
| Memphis Gastroenterology Group | Memphis | Tennessee | 38120 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| Baylor College of Medicine-VAMC | Houston | Texas | 77030 | — |
| McGuire VAMC | Richmond | Virginia | 23249 | — |
| Northwest Gastroenterolgy Assoc. | Bellevue | Washington | 98004 | — |
| Spokane Digestive Disease Center | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00062816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 5, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00062816 live on ClinicalTrials.gov.